Inhibition Of Lipopolysaccharide-Induced Expression Of Inducible Nitric Oxide Synthase By Phenolic (3e)-4-(2-Hydroxyphenyl)But-3-En-2-One In Raw 264.7 Macrophages

Lt Tsao,Ps Tsai,Rh Lin,Lj Huang,Sc Kuo,Jp Wang
DOI: https://doi.org/10.1016/j.bcp.2005.05.032
IF: 6.1
2005-01-01
Biochemical Pharmacology
Abstract:The large amount of nitric oxide (NO) produced by inducible NO synthase (iNOS) contributes to cellular injury in inflammatory disease. In the present study, a novel synthetic compound (3E)-4-(2-hydroxyphenyl)but-3-en-2-one (HPB) was found to inhibit lipopolysaccharide (LPS)-induced NO generation, but not through the inhibition of iNOS activity, in RAW 264.7 macrophages. Administration of HPB into mice also inhibited the LPS-induced increase in serum nitrite/nitrate levels. To evaluate the underlying mechanisms of HPB inhibition of NO generation, the expression of the WOS gene in RAW 264.7 macrophages was examined. HPB abolished the LPS-induced expression of iNOS protein, iNOS mRNA and iNOS promoter activity in a similar concentration-dependent manner. LPS-induced nuclear factor-kappa B (NF-kappa B) DNA binding and NF-kappa B-dependent reporter gene activity were both significantly inhibited by HPB. This effect was mediated through the inhibition of inhibitory factor-KBot (I kappa B alpha) phosphorylation and degradation, and of p65 nuclear translocation. HPB had no effect on the LPS-induced phosphorylation of extracellular signal -regulated kinase (ERK), p38 mitogen-activated protein kinases (MAPK), and c-Jun NH2-terminal kinase (JNK). However, HPB suppressed the LPS-induced intracellular reactive oxygen species (ROS) production. These results indicate that HPB down-regulates WOS gene expression probably through the inhibition of LPS-induced intracellular ROS production, which has been implicated in the activation of NF-kappa B. (c) 2005 Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?